<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Deng Y</submitter><funding>National Natural Science Foundation of China</funding><pagination>1355-1364</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11028128</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>67(9)</volume><pubmed_abstract>Immune cell activation occurs concurrently with metabolic reprogramming. As important components of the tumor microenvironment, monocytic myeloid-derived suppressor cells (M-MDSCs) are featured by their potent immunosuppressive abilities on anti-tumor effector cells. However, little is known about the contribution of metabolic adaptations to their suppressive roles. In this study, we found that tumor-infiltrating M-MDSCs had the same phenotype with splenic M-MDSCs. Compared with splenic M-MDSCs, tumor-infiltrating M-MDSCs exhibited stronger suppressive activities which was accompanied by higher glycolysis. Inhibition of glycolysis impaired the suppressive function of tumor M-MDSCs. Meanwhile, the results demonstrated that mTOR was responsible for this function regulation. mTOR inhibition b</pubmed_abstract><journal>Cancer immunology, immunotherapy : CII</journal><pubmed_title>mTOR-mediated glycolysis contributes to the enhanced suppressive function of murine tumor-infiltrating monocytic myeloid-derived suppressor cells.</pubmed_title><pmcid>PMC11028128</pmcid><funding_grant_id>81730045</funding_grant_id><funding_grant_id>91527305</funding_grant_id><funding_grant_id>31570892</funding_grant_id><pubmed_authors>Yang J</pubmed_authors><pubmed_authors>Qian J</pubmed_authors><pubmed_authors>Zhang D</pubmed_authors><pubmed_authors>Chu Y</pubmed_authors><pubmed_authors>Luo F</pubmed_authors><pubmed_authors>Liu R</pubmed_authors><pubmed_authors>Yu H</pubmed_authors><pubmed_authors>Deng Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>mTOR-mediated glycolysis contributes to the enhanced suppressive function of murine tumor-infiltrating monocytic myeloid-derived suppressor cells.</name><description>Immune cell activation occurs concurrently with metabolic reprogramming. As important components of the tumor microenvironment, monocytic myeloid-derived suppressor cells (M-MDSCs) are featured by their potent immunosuppressive abilities on anti-tumor effector cells. However, little is known about the contribution of metabolic adaptations to their suppressive roles. In this study, we found that tumor-infiltrating M-MDSCs had the same phenotype with splenic M-MDSCs. Compared with splenic M-MDSCs, tumor-infiltrating M-MDSCs exhibited stronger suppressive activities which was accompanied by higher glycolysis. Inhibition of glycolysis impaired the suppressive function of tumor M-MDSCs. Meanwhile, the results demonstrated that mTOR was responsible for this function regulation. mTOR inhibition b</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Sep</publication><modification>2025-04-22T20:45:41.968Z</modification><creation>2025-04-06T03:16:01.782Z</creation></dates><accession>S-EPMC11028128</accession><cross_references><pubmed>29968153</pubmed><doi>10.1007/s00262-018-2177-1</doi></cross_references></HashMap>